vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $16.9M, roughly 1.2× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 86.1%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-97.3M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 56.1%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
AGIO vs FVCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $16.9M |
| Net Profit | $-108.0M | — |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 43.7% |
| Net Margin | -541.1% | — |
| Revenue YoY | 86.1% | 4377.5% |
| Net Profit YoY | -11.9% | — |
| EPS (diluted) | $-1.86 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $16.9M | ||
| Q3 25 | $12.9M | $416.0K | ||
| Q2 25 | $12.5M | $15.8M | ||
| Q1 25 | $8.7M | $382.0K | ||
| Q4 24 | $10.7M | $378.0K | ||
| Q3 24 | $9.0M | $412.0K | ||
| Q2 24 | $8.6M | $415.0K | ||
| Q1 24 | $8.2M | $359.0K |
| Q4 25 | $-108.0M | — | ||
| Q3 25 | $-103.4M | $5.6M | ||
| Q2 25 | $-112.0M | $5.7M | ||
| Q1 25 | $-89.3M | $5.2M | ||
| Q4 24 | $-96.5M | — | ||
| Q3 24 | $947.9M | $4.7M | ||
| Q2 24 | $-96.1M | $4.2M | ||
| Q1 24 | $-81.5M | $1.3M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 43.7% | ||
| Q3 25 | -907.4% | — | ||
| Q2 25 | -1020.1% | 45.9% | ||
| Q1 25 | -1222.0% | — | ||
| Q4 24 | -1165.3% | — | ||
| Q3 24 | -1146.9% | — | ||
| Q2 24 | -1228.3% | — | ||
| Q1 24 | -1124.3% | — |
| Q4 25 | -541.1% | — | ||
| Q3 25 | -803.1% | 1341.1% | ||
| Q2 25 | -899.4% | 36.0% | ||
| Q1 25 | -1023.3% | 1352.1% | ||
| Q4 24 | -899.6% | — | ||
| Q3 24 | 10574.7% | 1133.3% | ||
| Q2 24 | -1115.7% | 1001.2% | ||
| Q1 24 | -995.8% | 373.3% |
| Q4 25 | $-1.86 | $0.31 | ||
| Q3 25 | $-1.78 | $0.31 | ||
| Q2 25 | $-1.93 | $0.31 | ||
| Q1 25 | $-1.55 | $0.28 | ||
| Q4 24 | $-1.44 | $0.27 | ||
| Q3 24 | $16.22 | $0.25 | ||
| Q2 24 | $-1.69 | $0.23 | ||
| Q1 24 | $-1.45 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $253.6M |
| Total Assets | $1.3B | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | — | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — | ||
| Q1 24 | $118.8M | — |
| Q4 25 | $1.2B | $253.6M | ||
| Q3 25 | $1.3B | $249.8M | ||
| Q2 25 | $1.4B | $243.2M | ||
| Q1 25 | $1.5B | $242.3M | ||
| Q4 24 | $1.5B | $235.4M | ||
| Q3 24 | $1.6B | $230.8M | ||
| Q2 24 | $660.5M | $226.5M | ||
| Q1 24 | $743.9M | $220.7M |
| Q4 25 | $1.3B | $2.3B | ||
| Q3 25 | $1.4B | $2.3B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.6B | $2.2B | ||
| Q4 24 | $1.7B | $2.2B | ||
| Q3 24 | $1.8B | $2.3B | ||
| Q2 24 | $773.1M | $2.3B | ||
| Q1 24 | $849.7M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $23.9M |
| Free Cash FlowOCF − Capex | $-97.3M | $23.8M |
| FCF MarginFCF / Revenue | -487.5% | 140.7% |
| Capex IntensityCapex / Revenue | 5.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $23.9M | ||
| Q3 25 | $-88.2M | $7.6M | ||
| Q2 25 | $-77.1M | $3.3M | ||
| Q1 25 | $-111.5M | $5.4M | ||
| Q4 24 | $-133.2M | $18.2M | ||
| Q3 24 | $-84.2M | $4.7M | ||
| Q2 24 | $-72.6M | $1.6M | ||
| Q1 24 | $-99.9M | $7.2M |
| Q4 25 | $-97.3M | $23.8M | ||
| Q3 25 | $-89.7M | $7.6M | ||
| Q2 25 | $-78.0M | $3.3M | ||
| Q1 25 | $-112.3M | $5.4M | ||
| Q4 24 | $-134.1M | $18.1M | ||
| Q3 24 | $-84.6M | $4.6M | ||
| Q2 24 | $-72.7M | $1.5M | ||
| Q1 24 | $-100.0M | $7.1M |
| Q4 25 | -487.5% | 140.7% | ||
| Q3 25 | -696.5% | 1818.0% | ||
| Q2 25 | -626.2% | 20.8% | ||
| Q1 25 | -1286.4% | 1413.6% | ||
| Q4 24 | -1250.1% | 4786.0% | ||
| Q3 24 | -944.2% | 1121.8% | ||
| Q2 24 | -844.4% | 361.2% | ||
| Q1 24 | -1221.2% | 1988.3% |
| Q4 25 | 5.6% | 0.3% | ||
| Q3 25 | 12.1% | 0.2% | ||
| Q2 25 | 7.0% | 0.1% | ||
| Q1 25 | 8.8% | 4.2% | ||
| Q4 24 | 9.0% | 37.3% | ||
| Q3 24 | 4.7% | 14.1% | ||
| Q2 24 | 1.8% | 12.8% | ||
| Q1 24 | 1.7% | 3.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
